SHUNXI FUND
SHUNXI FUND
Status:
Active
Similar Organizations
SCC Growth 2010 (HK)
SCC Growth 2010 (HK) is an investment fund.
Viki Fund
Viki Fund is an investment fund.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-12-21 | NeoCura | Shunxi Fund investment in Series A - NeoCura | 500 M CNY |
| 2019-07-15 | Bayuegua | Shunxi Fund investment in Series A - Bayuegua | 50 M CNY |
| 2018-08-08 | Bayuegua | Shunxi Fund investment in Angel Round - Bayuegua | 2.93 M USD |
| 2017-10-17 | Xeno Dynamics | Shunxi Fund investment in Series A - Xeno Dynamics | 10 M CNY |
| 2016-09-01 | QED Technique | Shunxi Fund investment in Series A - QED Technique | 20 M CNY |
More informations about "Shunxi Fund"
Shunxi Fund - Investments, Portfolio & Company Exits - Crunchbase
Shunxi Fund has made 18 investments. Their most recent investment was on Aug 29, 2024, when Weiyuan Synthetic Biotechnology raised. obfuscated. obfuscated. How many investments has …See details»
Shun Xi Fund Investor Profile: Portfolio & Exits - PitchBook
Aug 14, 2023 How many investments has Shun Xi Fund made? Shun Xi Fund has made 38 investments. What has Shun Xi Fund invested in? Shun Xi Fund has made numerous …See details»
Beijing Shunxi Fund: Performance - PitchBook
Beijing Shunxi Fund is a 2015 vintage venture capital fund managed by State-owned Capital Operation and Management Center of Beijing. The fund is located in Beijing and will invest in …See details»
Shunxi Private Equity Fund Management - CB Insights
Jul 27, 2020 Shunxi Private Equity Fund Management is a fund management company that operates and manages various investment solutions. It was founded in 2015 and is based in …See details»
Beijing Gongrong Shunxi RMB Fund: Performance - PitchBook
Beijing Gongrong Shunxi RMB Fund is a venture capital fund managed by Shun Xi Fund. The fund is located in Beijing, China and prefers to invest in China. The fund targets investments in …See details»
Shunxi Fund - Crunchbase
Shunxi Fund and Beijing Dongcheng District Science and Technology Innovation Industry Investment Fund share similar descriptions . Save These companies are similar. Huoban Fund …See details»
Guoguan Shunxi Fund - Investor Profile, Portfolio & Team - Tracxn
Oct 22, 2024 Co-investors of Guoguan Shunxi Fund. Over the past . year, 7 investors have co-invested in Guoguan Shunxi Fund's portfolio companies.. This includes only funds.Invested …See details»
Shunxi Fund investor portfolio, rounds & team | Dealroom.co
Shunxi Fund Venture capital Claimed. Overview. Portfolio (0) Notes. Recent News about Shunxi Fund Edit. Portfolio analysis ...See details»
Brise Pharmaceuticals Raises nearly $20M in Series Pre-A and Pre …
Apr 22, 2024 This Pre-A round is led by Shunxi Fund, followed by Cnfuel Capital, Vinner Therapeutics and existing investors such as Qiming Venture Partners and BioTrack Capital. ...See details»
Brise Pharmaceuticals Raises nearly $20M in Series Pre-A and Pre …
Apr 23, 2024 This Pre-A round is led by Shunxi Fund, followed by Cnfuel Capital, Vinner Therapeutics and existing investors such as Qiming Venture Partners and BioTrack Capital. …See details»
Brise Pharmaceuticals Raises nearly $20M in Series Pre-A and
This Pre-A round is led by Shunxi Fund, followed by Cnfuel Capital, Vinner Therapeutics and existing investors such as Qiming Venture Partners and BioTrack Capital. ... The …See details»
Shunlong Private Equity Bond Investment Fund Manager Profile
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, …See details»
Shunxi Fund - Updates, News, Events, Signals & Triggers
Shunxi Fund is an investment Fund.See details»
Shanghai Junshi Biosciences Co., Ltd. - MarketScreener.com
Nov 13, 2023 Immupeutics Medical Technology Co., Ltd. announced that it has raised of tens of millions of yuan in a round of funding led by new investor Shunxi Fund on November 14, 2023. …See details»
Brise Pharmaceuticals raises nearly $20M in series Pre-A financing
Apr 23, 2024 Brise Pharmaceuticals Co., LTD. , a pioneering company specializing in innovative treatments for acute and chronic pain, has recently completed Pre-A and Pre-A+ financing …See details»
Official Announcement | NeoCura Completed the Series A
On December 21, 2021, NeoCura Bio-Medical Technology Co., Ltd (“NeoCura”) announced the completion of the A+ round financing of RMB 500 Million Yuan. This round of financing was …See details»
Cartherics grants Shunxi Licence for CAR-T Cell Therapy for …
Melbourne, Australia, 28 April 2023 – Cartherics Pty Ltd ("Cartherics"), a biotechnology company developing immune cell therapies for the treatment of cancer, announced today that it has …See details»
Series A - Hunan Tree Industrial Manufacturing - 2023-08-02 ...
Aug 2, 2023 Organization Name . Hunan Tree Industrial Manufacturing . Announced Date Aug 2, 2023; Funding Type Series A; Funding Stage ... CN¥100M. Lead Investors. Edit Lead …See details»
Brise Pharmaceuticals Raises nearly $20M in Series Pre-A and
Apr 23, 2024 This Pre-A round is led by Shunxi Fund, followed by Cnfuel Capital, ... neuropathic and musculoskeletal pain. The organization's vision is to provide safe, effective, ...See details»